NCT00464399View on ClinicalTrials.gov

Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2012

Conditions
De Novo Renal Transplantation
Interventions
DRUG

everolimus

Trial Locations (1)

Unknown

Novartis Investigative Site,, Oslo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY